Mallinckrodt plc to Report Earnings Results for First Quarter 2025 | MNK Stock News

Apr 10, 2025

Mallinckrodt plc (MNK, Financial) to announce Q1 2025 earnings on May 6, 2025.
Investor conference call scheduled at 8:30 a.m. ET alongside the earnings release.
Multiple channels available for investors to participate in the earnings call.

Mallinckrodt plc (MNK), a global specialty pharmaceutical company, has announced that it will release its financial results for the first quarter of 2025 on Tuesday, May 6, 2025. The release will be accompanied by a conference call for investors, scheduled to begin at 8:30 a.m. ET on the same day.

Investors are invited to participate in the conference via several channels. These include a live call registration system, an audio-only webcast, and the company's Investor Relations webpage. The audio webcast can be accessed at this link or through Mallinckrodt's Investor Relations page on their official website.

Mallinckrodt, headquartered in Dublin, Ireland, focuses on developing, manufacturing, and marketing specialty pharmaceutical products and therapies. The company's areas of expertise include autoimmune and rare diseases, neonatal respiratory critical care therapies, and gastrointestinal products, among others.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.